Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Long-Term Outcomes of Adult Lung Transplantation Recipients: A Single-Center Experience in South Korea

  • Jo, Kyung-Wook (Division of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hong, Sang-Bum (Division of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Dong Kwan (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jung, Sung Ho (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Hyeong Ryul (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Se Hoon (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Geun Dong (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sang-Oh (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Do, Kyung-Hyun (Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chae, Eun Jin (Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, In-Cheol (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Dae-Kee (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, In Ok (Organ Transplantation Center, Asan Medical Center) ;
  • Park, Seung-Il (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Shim, Tae Sun (Division of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2019.02.26
  • Accepted : 2019.05.21
  • Published : 2019.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Recently, the number of lung transplants in South Korea has increased. However, the long-term outcome data is limited. In this study, we aimed to investigate the long-term outcomes of adult lung transplantation recipients. Methods: Among the patients that underwent lung transplantation at a tertiary referral center in South Korea between 2008 and 2017, adults patient who underwent deceased-donor lung transplantation with available follow-up data were enrolled. Their medical records were retrospectively reviewed. Results: Through eligibility screening, we identified 60 adult patients that underwent lung (n=51) or heart-lung transplantation (n=9) during the observation period. Idiopathic pulmonary fibrosis (46.7%, 28/60) was the most frequent cause of lung transplantation. For all the 60 patients, the median follow-up duration for post-transplantation was 2.6 years (range, 0.01-7.6). During the post-transplantation follow-up period, 19 patients (31.7%) died at a median duration of 194 days. The survival rates were 75.5%, 67.6%, and 61.8% at 1 year, 3 years, and 5 years, respectively. Out of the 60 patients, 8 (13.3%) were diagnosed with chronic lung allograft dysfunction (CLAD), after a mean duration of $3.3{\pm}2.8years$ post-transplantation. The CLAD development rate was 0%, 17.7%, and 25.8% at 1 year, 3 years, and 5 years, respectively. The most common newly developed post-transplantation comorbidity was the chronic kidney disease (CKD; 54.0%), followed by diabetes mellitus (25.9%). Conclusion: Among the adult lung transplantation recipients at a South Korea tertiary referral center, the long-term survival rates were favorable. The proportion of patients who developed CLAD was not substantial. CKD was the most common post-transplantation comorbidity.

Keywords

References

  1. Rutherford RM, Fisher AJ, Hilton C, Forty J, Hasan A, Gould FK, et al. Functional status and quality of life in patients surviving 10 years after lung transplantation. Am J Transplant 2005;5:1099-104. https://doi.org/10.1111/j.1600-6143.2004.00803.x
  2. Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant 2017;36:1047-59. https://doi.org/10.1016/j.healun.2017.07.016
  3. Morris PJ. Transplantation: a medical miracle of the 20th century. N Engl J Med 2004;351:2678-80. https://doi.org/10.1056/NEJMp048256
  4. Waki K. UNOS Liver Registry: ten year survivals. Clin Transpl 2006:29-39.
  5. Verleden GM, Vos R, Vanaudenaerde B, Dupont L, Yserbyt J, Van Raemdonck D, et al. Current views on chronic rejection after lung transplantation. Transpl Int 2015;28:1131-9. https://doi.org/10.1111/tri.12579
  6. Korean Network for Organ Sharing. National data for organ transplantation [Internet]. Seoul: Korean Network for Organ Sharing; 2019 [cited 2019 May 7]. Available from: https://www.konos.go.kr/konosis/index.jsp.
  7. Cho EN, Haam SJ, Kim SY, Chang YS, Paik HC. Anastomotic airway complications after lung transplantation. Yonsei Med J 2015;56:1372-8. https://doi.org/10.3349/ymj.2015.56.5.1372
  8. Yun JH, Lee SO, Jo KW, Choi SH, Lee J, Chae EJ, et al. Infections after lung transplantation: time of occurrence, sites, and microbiologic etiologies. Korean J Intern Med 2015;30:506-14. https://doi.org/10.3904/kjim.2015.30.4.506
  9. Lee SH, Park MS, Song JH, Kim YS, Lee JG, Paik HC, et al. Perioperative factors associated with 1-year mortality after lung transplantation: a single-center experience in Korea. J Thorac Dis 2017;9:4006-16. https://doi.org/10.21037/jtd.2017.09.21
  10. Jeong YH, Choi S, Park SI, Kim DK; Asan Medical Center Lung Transplantation Team. Clinical outcomes of lung transplantation: experience at Asan Medical Center. Korean J Thorac Cardiovasc Surg 2018;51:22-8. https://doi.org/10.5090/kjtcs.2018.51.1.22
  11. Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant 2014;33:127-33. https://doi.org/10.1016/j.healun.2013.10.022
  12. Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Van Raemdonck DE, Dupont LJ, et al. Restrictive chronic lung allograft dysfunction: where are we now? J Heart Lung Transplant 2015;34:625-30. https://doi.org/10.1016/j.healun.2014.11.007
  13. Vos R, Verleden SE, Verleden GM. Chronic lung allograft dysfunction: evolving practice. Curr Opin Organ Transplant 2015;20:483-91. https://doi.org/10.1097/MOT.0000000000000236
  14. Patti MG, Vela MF, Odell DD, Richter JE, Fisichella PM, Vaezi MF. The intersection of GERD, aspiration, and lung transplantation. J Laparoendosc Adv Surg Tech A 2016;26:501-5. https://doi.org/10.1089/lap.2016.0170
  15. Basseri B, Conklin JL, Pimentel M, Tabrizi R, Phillips EH, Simsir SA, et al. Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates. Ann Thorac Surg 2010;90:1630-6. https://doi.org/10.1016/j.athoracsur.2010.06.104
  16. Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Van Raemdonck DE, et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 2011;37:164-72. https://doi.org/10.1183/09031936.00068310
  17. Kim WY, Hong SB. Humidifier disinfectant-associated lung injury: six years after the tragic event. Tuberc Respir Dis 2017;80:351-7. https://doi.org/10.4046/trd.2017.0048
  18. Korean Network for Organ Sharing. National data for organ transplantation [Internet]. Seoul: Korean Network for Organ Sharing; 2019 [cited 2019 May 7]. Available from: https://www.konos.go.kr/konosis/common/bizlogic.jsp?fwdUrl=/sub4/sub04_06_01_list.jsp&boardid=22&event=search2&svc=web.wm.law.
  19. Schaffer JM, Singh SK, Reitz BA, Zamanian RT, Mallidi HR. Single- vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need. JAMA 2015;313:936-48. https://doi.org/10.1001/jama.2015.1175
  20. Puri V, Patterson GA, Meyers BF. Single versus bilateral lung transplantation: do guidelines exist? Thorac Surg Clin 2015;25:47-54. https://doi.org/10.1016/j.thorsurg.2014.09.007
  21. George TJ, Arnaoutakis GJ, Beaty CA, Pipeling MR, Merlo CA, Conte JV, et al. Acute kidney injury increases mortality after lung transplantation. Ann Thorac Surg 2012;94:185-92. https://doi.org/10.1016/j.athoracsur.2011.11.032
  22. Arnaoutakis GJ, George TJ, Robinson CW, Gibbs KW, Orens JB, Merlo CA, et al. Severe acute kidney injury according to the RIFLE (risk, injury, failure, loss, end stage) criteria affects mortality in lung transplantation. J Heart Lung Transplant 2011;30:1161-8. https://doi.org/10.1016/j.healun.2011.04.013
  23. Jayarajan SN, Taghavi S, Komaroff E, Brann S, Horai T, Cordova F, et al. Impact of extracorporeal membrane oxygenation or mechanical ventilation as bridge to combined heart-lung transplantation on short-term and long-term survival. Transplantation 2014;97:111-5. https://doi.org/10.1097/TP.0b013e3182a860b8
  24. Crotti S, Iotti GA, Lissoni A, Belliato M, Zanierato M, Chierichetti M, et al. Organ allocation waiting time during extracorporeal bridge to lung transplant affects outcomes. Chest 2013;144:1018-25. https://doi.org/10.1378/chest.12-1141
  25. Hayanga AJ, Du AL, Joubert K, Tuft M, Baird R, Pilewski J, et al. Mechanical ventilation and extracorporeal membrane oxygenation as a bridging strategy to lung transplantation: significant gains in survival. Am J Transplant 2018;18:125-35. https://doi.org/10.1111/ajt.14422
  26. George TJ, Beaty CA, Kilic A, Shah PD, Merlo CA, Shah AS. Outcomes and temporal trends among high-risk patients after lung transplantation in the United States. J Heart Lung Transplant 2012;31:1182-91. https://doi.org/10.1016/j.healun.2012.07.001
  27. Verleden SE, Sacreas A, Vos R, Vanaudenaerde BM, Verleden GM. Advances in understanding bronchiolitis obliterans after lung transplantation. Chest 2016;150:219-25. https://doi.org/10.1016/j.chest.2016.04.014
  28. Yusen RD, Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report, 2013; focus theme: age. J Heart Lung Transplant 2013;32:965-78. https://doi.org/10.1016/j.healun.2013.08.007
  29. Bloom RD, Doyle AM. Kidney disease after heart and lung transplantation. Am J Transplant 2006;6:671-9. https://doi.org/10.1111/j.1600-6143.2006.01248.x
  30. Floreth T, Bhorade SM, Ahya VN. Conventional and novel approaches to immunosuppression. Clin Chest Med 2011;32:265-77. https://doi.org/10.1016/j.ccm.2011.02.012
  31. Scheffert JL, Raza K. Immunosuppression in lung transplantation. J Thorac Dis 2014;6:1039-53.
  32. Shitrit D, Rahamimov R, Gidon S, Bakal I, Bargil-Shitrit A, Milton S, et al. Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: results of a controlled pilot study. Kidney Int 2005;67:1471-5. https://doi.org/10.1111/j.1523-1755.2005.00224.x
  33. Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, et al. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. Transplantation 2010;89:864-72. https://doi.org/10.1097/TP.0b013e3181cbac2d

Cited by

  1. Looking Beyond the Allograft Survival: Long-Term, 5-Year Renal Outcome in Lung Transplant Recipients vol.53, pp.10, 2021, https://doi.org/10.1016/j.transproceed.2021.09.037